Cargando…
A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Association for the Study of Lung Cancer. Published by Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270552/ https://www.ncbi.nlm.nih.gov/pubmed/32243919 http://dx.doi.org/10.1016/j.jtho.2020.03.021 |
| _version_ | 1783541920444710912 |
|---|---|
| author | Bonomi, Lucia Ghilardi, Laura Arnoldi, Ermenegildo Tondini, Carlo Alberto Bettini, Anna Cecilia |
| author_facet | Bonomi, Lucia Ghilardi, Laura Arnoldi, Ermenegildo Tondini, Carlo Alberto Bettini, Anna Cecilia |
| author_sort | Bonomi, Lucia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7270552 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | International Association for the Study of Lung Cancer. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72705522020-06-05 A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab Bonomi, Lucia Ghilardi, Laura Arnoldi, Ermenegildo Tondini, Carlo Alberto Bettini, Anna Cecilia J Thorac Oncol Letter to the Editor International Association for the Study of Lung Cancer. Published by Elsevier Inc. 2020-06 2020-03-31 /pmc/articles/PMC7270552/ /pubmed/32243919 http://dx.doi.org/10.1016/j.jtho.2020.03.021 Text en © 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Bonomi, Lucia Ghilardi, Laura Arnoldi, Ermenegildo Tondini, Carlo Alberto Bettini, Anna Cecilia A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab |
| title | A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab |
| title_full | A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab |
| title_fullStr | A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab |
| title_full_unstemmed | A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab |
| title_short | A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab |
| title_sort | rapid fatal evolution of coronavirus disease-19 in a patient with advanced lung cancer with a long-time response to nivolumab |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270552/ https://www.ncbi.nlm.nih.gov/pubmed/32243919 http://dx.doi.org/10.1016/j.jtho.2020.03.021 |
| work_keys_str_mv | AT bonomilucia arapidfatalevolutionofcoronavirusdisease19inapatientwithadvancedlungcancerwithalongtimeresponsetonivolumab AT ghilardilaura arapidfatalevolutionofcoronavirusdisease19inapatientwithadvancedlungcancerwithalongtimeresponsetonivolumab AT arnoldiermenegildo arapidfatalevolutionofcoronavirusdisease19inapatientwithadvancedlungcancerwithalongtimeresponsetonivolumab AT tondinicarloalberto arapidfatalevolutionofcoronavirusdisease19inapatientwithadvancedlungcancerwithalongtimeresponsetonivolumab AT bettiniannacecilia arapidfatalevolutionofcoronavirusdisease19inapatientwithadvancedlungcancerwithalongtimeresponsetonivolumab AT bonomilucia rapidfatalevolutionofcoronavirusdisease19inapatientwithadvancedlungcancerwithalongtimeresponsetonivolumab AT ghilardilaura rapidfatalevolutionofcoronavirusdisease19inapatientwithadvancedlungcancerwithalongtimeresponsetonivolumab AT arnoldiermenegildo rapidfatalevolutionofcoronavirusdisease19inapatientwithadvancedlungcancerwithalongtimeresponsetonivolumab AT tondinicarloalberto rapidfatalevolutionofcoronavirusdisease19inapatientwithadvancedlungcancerwithalongtimeresponsetonivolumab AT bettiniannacecilia rapidfatalevolutionofcoronavirusdisease19inapatientwithadvancedlungcancerwithalongtimeresponsetonivolumab |